Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Small-Cap Index Fund

T. Rowe Price Small-Cap Index Fund (TRCSX) proxy voting record 2024-2025

Fund family: T. Rowe Price · Filed by T. Rowe Price Index Trust, Inc. (CIK 858581) · SEC series S000051327

Share classes and tickers: TRCSX (C000161838), TRSYX (C000161837), TRZIX (C000219329)

2023-20242024-20252025-2026

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 15,606 with, 68 against, 0 abstentions (not counted as with management); 11 items carried no recommendation; 17 split votes are in neither count. Shareholder proposals: 28 FOR, 18 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (226,567 ballot items across 105 funds and accounts), counted the same way for this fund.

2024-2025This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)89.0%15,14494.2%195,113
Backed environmental and social shareholder proposals at US companiesn/a92.1%4,342

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections10,69333
Audit-related1,8853
Say-on-Pay1,8152
Compensation6590
Corporate Governance45119
Capital Structure2150
Extraordinary Transactions1381
Shareholder Rights and Defenses511
Environment or Climate55
Human Rights or Human Capital/workforce33

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
AGILON HEALTH INC.May 28, 2025$3M40
REVOLUTION MEDICINES INC.June 26, 2025$3M60
INSMED INC.May 15, 2025$2M50
GUARDANT HEALTH INC.June 18, 2025$2M60
BLOOM ENERGY CORP.May 14, 2025$1M60
HALOZYME THERAPEUTICS INC.May 1, 2025$1M40
GLAUKOS CORP.May 29, 2025$1M50
BRIDGEBIO PHARMA INC.June 20, 2025$961,585100

Notable votes against management

MeetingCompanyProposalFundMgmt
March 10, 2025SANMINA CORP.To consider and vote upon the stockholder proposal entitled "Proposal 5 - Special Shareholder Meeting Improvement," requesting that the Board of Directors take action as necessary to amend the existing right for shareholders to call a special meeting. Shareholder proposalForAgainst
May 22, 2025MERITAGE HOMES CORP.Shareholder proposal to support transparency in political spending. Shareholder proposalAgainstFor
April 23, 2025WARRIOR MET COAL INC.STOCKHOLDER PROPOSAL: To adopt a resolution requesting an assessment of the Company's respect for the internationally recognized human rights of freedom of association and collective bargaining, if properly presented. Shareholder proposalAgainstFor
May 13, 2025ASBURY AUTOMOTIVE GROUP INC.Stockholder proposal to implement simple majority vote. Shareholder proposalForAgainst
May 13, 2025ICU MEDICAL INC.To approve, on an advisory basis, a stockholder proposal to adopt simple majority voting. Shareholder proposalForAgainst
May 13, 2025GROUP 1 AUTOMOTIVE INC.Shareholder Proposal: Simple Majority Vote. Shareholder proposalForAgainst
May 6, 2025SKYWEST INC.A shareholder proposal regarding collective bargaining policy. Shareholder proposalForAgainst
April 24, 2025DANA INC.Shareholder proposal to require an independent Board Chairman. Shareholder proposalAgainstFor
May 21, 2025NATIONAL HEALTH INVESTORS INC.Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES OPPOSED BY LAND & BUILDINGS NOMINEES: Robert G. AdamsWithholdFor
May 21, 2025NATIONAL HEALTH INVESTORS INC.Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES OPPOSED BY LAND & BUILDINGS NOMINEES: James R. JobeWithholdFor
May 15, 2025POWER INTEGRATIONS INC.To consider, if properly presented at the Annual Meeting, a stockholder proposal requesting the Board of Directors to adopt a policy and amend governing documents in order that two separate individuals hold the office of Chairman of the Board and the office of the Chief Executive Officer. Shareholder proposalAgainstFor
May 1, 2025WOLVERINE WORLD WIDE INC.Shareholder proposal regarding greenhouse gas emissions disclosures and targets. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (9 in 2024-2025), and how the fund voted the items on its ballot.

Every vote, 2024-2025

The vote-by-vote list is kept for the latest season, 2025-2026. Every vote of 2024-2025 is in the interactive database, company by company, under T. Rowe Price.

About this fund’s record

In the 2024-2025 proxy season, T. Rowe Price Small-Cap Index Fund (TRCSX) voted at 2,047 shareholder meetings of 1,925 companies, on 15,920 ballot items in all. Where management made a recommendation, the fund followed it on 99.6% of the items and voted against it 68 times. Its most frequent area of disagreement was director elections (33 of its votes against management). It voted on 62 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (89.0% against 94.2%). 9 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.